- Raised $4.5M funding round, Nov 2014
About
Efranat Pharma is developing an anticancer immunotherapy treatment based on a natural plasma protein molecule. The technology is based on the concept of engaging the bodys own immune system and harnessing it against cancer. Efranat has succeeded in engineering a natural vitamin D binding protein into a potent immune modulator to fight cancer and chronic viral diseases. The companys primary product, EF-022, is an immunomodulator that activates macrophages, a group of white blood cells that play a key role in the immune systems defense against cancer. The product is manufactured and processed under GMP in a procedure that mimics the natural process in the body. A test involving 14 dogs with cancer that were treated with EF-022 showed promising results. Efranat is currently conducting a phase 1 clinical trial in human cancer patients with advanced solid tumors at the Sheba Medical Center.
Funding history · 1 round · $4.5M total
Q&A
- What is Efranat Pharma's primary focus?
- Efranat Pharma is developing an anticancer immunotherapy treatment based on a natural plasma protein molecule, aiming to engage the body's own immune system against cancer.
- What is the status of Efranat Pharma?
- Efranat Pharma is currently inactive, having ceased operations in November 2018.
- When was Efranat Pharma founded?
- Efranat Pharma was founded in December 2009.
- What is Efranat Pharma's main product?
- Efranat Pharma's primary product is EF-022, an immunomodulator designed to activate macrophages to fight cancer and chronic viral diseases.
- What was the total amount of funding raised by Efranat Pharma?
- Efranat Pharma raised a total of $4,500,000.
- When did Efranat Pharma complete its last funding round and who were the investors?
- Efranat Pharma completed its last funding round in November 2014, with investors including Yuval Yanai and Isaac-Friedman.
- How many employees did Efranat Pharma have?
- Efranat Pharma had an employee count in the 11-50 range.
- Where is Efranat Pharma headquartered?
- Efranat Pharma is headquartered in Rehovot, Center District, Israel.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/2679683 |
Identifiers & details
| Founded | 2009-12 |
|---|---|
| Employees (exact) | 30 |
| Status reason | Non Active, Nov 2018 ceased to operate |